IndiaTickerInvestor Presentation - Beta Drugs LimitedNSE · investor presentation · pdf
Source filing Company dossier
Beta Drugs
NSE:BETA · ISIN INE351Y01019
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Beta Drugs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Reply to Clarification- Financial results - Beta Drugs LimitedNSE · financial results · pdf
Source filing Copy of Newspaper Publication - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Beta Drugs LimitedNSE · financial results · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Trading Window - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Spurt in Volume - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Beta Drugs LimitedNSE · financial results · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Beta Drugs LimitedNSE · conference call · pdf
Source filing Copy of Newspaper Publication - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Beta Drugs LimitedNSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Beta Drugs LimitedNSE · conference call · zip
Source filing Outcome of Board Meeting - Beta Drugs LimitedNSE · financial results · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Monitoring Agency Report - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Beta Drugs LimitedNSE · conference call · pdf
Source filing Outcome of Board Meeting - Beta Drugs LimitedNSE · financial results · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Price movement - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Trading Window - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Beta Drugs LimitedNSE · financial results · pdf
Source filing Monitoring Agency Report - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Corrigendum - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing General Updates - Beta Drugs LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Beta Drugs LimitedNSE · financial results · pdf
Source filing